Related references
Note: Only part of the references are listed.Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
Jen-Fu Hsu et al.
CANCERS (2021)
Transferrin-Decorated Niosomes with Integrated InP/ZnS Quantum Dots and Magnetic Iron Oxide Nanoparticles: Dual Targeting and Imaging of Glioma
Didem Ag Seleci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook
Fakhara Sabir et al.
DRUG DISCOVERY TODAY (2020)
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2020)
Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth
Kunho Chung et al.
JOURNAL OF DRUG TARGETING (2020)
Nanocarrier-based drug combination therapy for glioblastoma
Mengnan Zhao et al.
THERANOSTICS (2020)
Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles
Kuldeep Nigam et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
Zar Chi Soe et al.
PHARMACEUTICS (2019)
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
Franciele Aline Bruinsmann et al.
MOLECULES (2019)
Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro-In vivo Assessment
Nidhi Raval et al.
SCIENTIFIC REPORTS (2019)
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
Victor M. Pulgar
FRONTIERS IN NEUROSCIENCE (2019)
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
Hannah Strobel et al.
BIOMEDICINES (2019)
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
Mukta Agrawal et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
Fred C. Lam et al.
NATURE COMMUNICATIONS (2018)
Nanotechnology for treatment of glioblastoma multiforme
Justin S. Michael et al.
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2018)
Nanotechnology-based strategies as novel therapies in gliomas
Puja S. Gaikwad et al.
THERAPEUTIC DELIVERY (2018)
Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy
Ting Sun et al.
ONCOTARGET (2017)
Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion
Rajshree L. Shinde et al.
DRUG DELIVERY (2017)
Glioblastoma targeted therapy: updated approaches from recent biological insights
M. Touat et al.
ANNALS OF ONCOLOGY (2017)
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
Shanshan Wang et al.
NANOMATERIALS (2016)
A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates
Joana Bicker et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses
Anam Khan et al.
MOLECULAR PHARMACEUTICS (2016)
Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery
Angel Treasa Alex et al.
DRUG DELIVERY (2016)
Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
Chen Fang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: A safety studyle
Muna Aryal et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment
Huile Gao et al.
BIOMATERIALS (2014)
The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview
Per G. Djupesland et al.
THERAPEUTIC DELIVERY (2014)
Characterization and identification of suspected counterfeit miltefosine capsules
Thomas P. C. Dorlo et al.
ANALYST (2012)
Physicochemical Selectivity of the BBB Microenvironment Governing Passive Diffusion-Matching with a Porcine Brain Lipid Extract Artificial Membrane Permeability Model
Oksana Tsinman et al.
PHARMACEUTICAL RESEARCH (2011)
Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats
Zhengqi Dong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Site-specific opening of the blood-brain barrier
Steen J. Madsen et al.
JOURNAL OF BIOPHOTONICS (2010)
Increased Cellular Uptake of Biocompatible Superparamagnetic Iron Oxide Nanoparticles into Malignant Cells by an External Magnetic Field
Sara Prijic et al.
JOURNAL OF MEMBRANE BIOLOGY (2010)
Transferrin Receptor 2 Is Frequently and Highly Expressed in Glioblastomas
Alessia Calzolari et al.
TRANSLATIONAL ONCOLOGY (2010)
In vitro evaluation of in situ gels as short term vitreous substitutes
S. Suri et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Miltefosine-cholesterol interactions:: A monolayer study
IR Gómez-Serranillos et al.
LANGMUIR (2004)
Modulation of multidrug-resistance-associated P-glycoprotein in human U-87 MG and HUV-ECC cells with antisense oligodeoxynucleotides to MDR1 mRNA
M Rittierodt et al.
PATHOBIOLOGY (2004)
Disposition and pharmacokinetics of temozolomide in rat
L Reyderman et al.
XENOBIOTICA (2004)
Mouse hippocampal organotypic tissue cultures exposed to in vitro ischemia show selective and delayed CA1 damage that is aggravated by glucose
A Rytter et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Share Paper
